Sakar Healthcare surged 8.49% to Rs 408.95 after the company's oncology unit has attained EU GMP approval valid for three years from the audit date of 5th March 2024.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.